Showing results (161-170 of 311) with videos related to

Sort By:
Pageof 32
Il Giornale Di Chirurgia|July 11, 2013
Can herniation pit of the femoral neck mimic an acute appendicitis? A case reportA Volpi, O C Pannarale, G Mancusi Materi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1996
Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancerE Baldini, C Tibaldi, A Chella, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 1, 1991
[Intestinal hemorrhage in a milk-fed infant: a case of laryngo-tracheo-gastric duplication]L Fomia, A Cappellini, M G Casiraghi, et al.
Gynecologic Oncology|March 1, 1985
Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancerP F Conte, M R Sertoli, M Bruzzone, et al.
Breast Cancer Research and Treatment|November 1, 1990
Megestrol acetate: phase II study of a single daily administration in advanced breast cancerP Pronzato, F Brema, D Amoroso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinomaA Alama, F Merlo, S Chiara, et al.
Hormone Research|March 17, 2001
Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient childrenF Conte, S Diridollou, B Jouret, et al.
Anticancer Research|February 24, 2001
p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimenA Gadducci, C Cianci, S Cosio, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaksM Andreuccetti, G Allegrini, A Antonuzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2013
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patientsV Guarneri, M V Dieci, E Barbieri, et al.
Pageof 32